Skip to main content

Table 1 Demographic and clinical characteristics at baseline (n = 3266)

From: High self-efficacy – a predictor of reduced pain and higher levels of physical activity among patients with osteoarthritis: an observational study

Variable

Total

Low SE pain ≤62

High SE pain > 62

p-value

Low SE OS ≤68

High SE OS > 68

p-value

Paina, mean (SD)

 baseline

48.48 (18.48)

52.96 (16.86)

43.46 (18.88)

< 0.01c*

52.60 (17.46)

43.86 (18.48)

< 0.01c*

 3 months

37.68 (19.68)

42.35 (19.11)

32.56 (19.00)

< 0.01c*

42.17 (19.06)

32.92 (19.28)

< 0.01c*

 1 year

39.97 (20.34)

44.24 (19.26)

35.23 (20.45)

< 0.01c*

43.96 (19.73)

35.54 (20.19)

< 0.01c*

Physical activityb, mean (SD)

 baseline

5.22 (2.05)

5.12 (2.15)

5.33 (1.92)

< 0.01c*

4.99 (2.17)

5.47 (1.87)

< 0.01c*

 3 months

5.45 (1.76)

5.40 (1.81)

5.50 (1.70)

0.11c

5.29 (1.84)

5.60 (1.65)

< 0.01c*

 1 year

5.14 (1.91)

5.06 (1.99)

5.24 (1.81)

< 0.01*c

4.99 (2.01)

5.31 (1.78)

< 0.01c*

Age, yrs

 mean (SD)

64.73 (9.22)

66.33 (9.30)

64.01 (9.08)

< 0.01*c

65.42 (9.57)

63.90 (8.74)

< 0.01c*

 minmax

27–93

32–93

27–89

32–93

27–88

Gender,n(%)

 male

923 (28.26)

495 (28.98)

420 (27.50)

0.35d

465 (27.26)

442 (29.33)

0.19d

 female

2343 (71.74)

1213 (71.5)

1107 (72.50)

1241 (72.74)

1065 (70.67)

Marital status,n(%)

 cohabiting

2419 (74.29)

1235 (72.48)

1161 (76.23)

0.01d*

1208 (70.98)

1168 (77.66)

< 0.01d*

 living alone

837 (25.71)

469 (27.52)

362 (23.77)

494 (29.02)

336 (22.34)

Born in Sweden,n(%)

 yes

3013 (92.37)

1569 (91.92)

1419 (92.99)

0.25d

1559 (91.44)

1410 (93.63)

0.02d*

 no

249 (7.63)

138 (8.08)

107 (7.01)

146 (8.56)

96 (6.37)

Education,n(%)

 compulsory school

1213 (37.37)

714 (42.02)

484 (31.86)

< 0.01d*

710 (41.89)

478 (31.85)

< 0.01d*

 upper secondary school

1118 (34.44)

601 (35.37)

514 (33.84)

594 (35.04)

512 (34.11)

 university

915 (28.19)

384 (22.60)

521 (34.30)

391 (23.07)

511 (34.04)

BMI, kg/m2,n(%)

 underweight < 18.5

64 (2.01)

34 (2.04)

27 (1.82)

0.04d*

33 (1.99)

27 (1.84)

< 0.01d*

 normal weight 18.524.9

877 (27.59)

425 (25.56)

442 (29.76)

426 (25.72)

436 (29.66)

 overweight 2529.9

1338 (42.09)

706 (42.45)

618 (41.62)

678 (40.94)

636 (43.27)

 obese ≥30

900 (28.31)

498 (29.95)

398 (26.80)

519 (31.34)

371 (25.24)

Most affected joint,n(%)

 hip

894 (27.37)

498 (29.16)

388 (25.41)

0.02d*

492 (28.84)

388 (25.75)

0.05d

 knee

2372 (72.63)

1210 (70.84)

1139 (74.54)

1214 (71.16)

1119 (74.25)

Affected other hip/knee,n(%)

 no

1459 (45.13)

701 (41.55)

746 (49.18)

< 0.01d*

727 (43.12)

713 (47.63)

0.01d*

 yes

1774 (54.87)

986 (58.45)

771 (50.82)

959 (56.88)

784 (52.37)

Walking difficulty,n(%)

 no

539 (16.70)

176 (10.44)

357 (23.58)

< 0.01d*

178 (10.58)

352 (23.53)

< 0.01d*

 yes

2689 (83.3)

1510 (88.1)

1157 (76.42)

1505 (89.42)

1144 (76.47)

  1. Demographic and clinical characteristics at baseline for the total cohort (n = 3266) and separately for the groups of participants with low vs high self-efficacy for pain management and low vs high self-efficacy for management of other symptoms
  2. SD standard deviation, SE pain self-efficacy for pain management, SE OS self-efficacy for management of other symptoms, VAS visual analogue scale
  3. aMeasured using a VAS from 0 to 100; bdays per week of being physically active for ≥30 min; ct-test; d chi-square test
  4. *p-value< 0.05